Industry Analysis

The document stems from intelligence-driven research, including literature reviews and consultations with health stakeholders, validating findings through AmCham members to outline positions on hurdles impeding Kenya's path to WHO ML3 and Universal Health Coverage (UHC).​ Key challenges covered include institutional restructuring and intergovernmental coordination issues, poor health data quality despite e-Health policies, shortages of qualified personnel and medicines at primary care levels, complex regulatory frameworks raising business costs, constrained financing amid rising expenses and donor reliance, inconsistent guidelines across providers, and high health worker absenteeism. Opportunities emphasized involve rapid sector growth in drug manufacturing (Africa's largest pharma market in Kenya), vaccine production investments, job creation via tech advancements, hierarchical service improvements from community to specialized care, and public-private partnerships for efficient resource use.​ It advocates for solutions like streamlined provider accreditation, quality standards enforcement, financing boosts, guideline harmonization, and workforce training to foster equitable, sustainable healthcare aligned with national priorities.